Carlisle 公司 CSL
$375.74 −$3.22 (-0.85%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $376.00 +0.07%
开盘$372.24
昨收$378.96
当日区间$370.29 – $384.25
成交量275.1K
市值$14.52B
市盈率（TTM）21.2
股息率1.21%
CSL 相关新闻
匹配 Carlisle Companies 或代码 CSL 的头条新闻，按最新排序。
- CSL Target Price Raised 31% to A$174.00/Share by MacquarieCSL.AU 正面
- Morgan Stanley Maintains CSL LTD(CMXHF.US) With Buy Rating, Cuts Target Price to $123.25 负面
- UBS Maintains CSL LTD(CMXHF.US) With Buy Rating, Maintains Target Price $129.7
- CSL Raised to Accumulate From Hold by Ord Minnett CSL.AU 正面
- RBC Capital Upgrades CSL LTD(CMXHF.US) to Buy Rating, Raises Target Price to $152.48 正面
- Morgans Maintains CSL LTD(CMXHF.US) With Buy Rating, Cuts Target Price to $134.13 负面
- CSL Ltd: Agreements with U.S. on Drug Prices and Manufacturing
- D.A. Davidson Maintains Carlisle Companies(CSL.US) With Hold Rating, Raises Target Price to $410 正面
- Goldman Sachs Maintains Carlisle Companies(CSL.US) With Buy Rating
- A Quick Look at Today's Ratings for CSL LTD(CMXHF.US), With a Forecast Between $113.89 to $147.34
- A Quick Look at Today's Ratings for CSL LTD(CMXHF.US), With a Forecast Between $113.21 to $132.82
- CSL Price Target Raised 15% to A$181.00/Share by UBS 正面
- CSL Price Target Raised 25% to A$150.00/Share by Bell Potter 正面
- CSL Price Target Raised 23% to A$146.50/Share by Jefferies 正面
- UBS Maintains CSL LTD(CMXHF.US) With Buy Rating, Cuts Target Price to $111.83 负面
暂无评论——快来第一个聊聊 CSL。